Furthermore, treatment of HPASMCs isolated from PAH patients revealed an attenuated response to H2O2 (Figure 7B), or auranofin (Figure 7C), suggesting PAH HPASMCs encounter a more reducing environment than donor control cells and hence less prone to form disulfide-CDK4. The gene discussed is CDK4; the disease is pulmonary arterial hypertension.